Literature DB >> 22537491

Zebrafish bcl2l is a survival factor in thyroid development.

Immacolata Porreca1, Elena De Felice, Henrik Fagman, Roberto Di Lauro, Paolo Sordino.   

Abstract

Regulated cell death, defined in morphological terms as apoptosis, is crucial for organ morphogenesis. While differentiation of the thyroid gland has been extensively studied, nothing is yet known about the survival mechanisms involved in the development of this endocrine gland. Using the zebrafish model system, we aim to understand whether genes belonging to the Bcl-2 family that control apoptosis are implicated in regulation of cell survival during thyroid development. Evidence of strong Bcl-2 gene expression in mouse thyroid precursors prompted us to investigate the functions played by its zebrafish homologs during thyroid development. We show that the bcl2-like (bcl2l) gene is expressed in the zebrafish thyroid primordium. Morpholino-mediated knockdown and mutant analyses revealed that bcl2l is crucial for thyroid cell survival and that this function is tightly modulated by the transcription factors pax2a, nk2.1a and hhex. Also, the bcl2l gene appears to control a caspase-3-dependent apoptotic mechanism during thyroid development. Thyroid precursor cells require an actively maintained survival mechanism to properly proceed through development. The bcl2l gene operates in the inhibition of cell death under direct regulation of a thyroid specific set of transcription factors. This is the first demonstration of an active mechanism to ensure survival of the thyroid primordium during morphogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537491     DOI: 10.1016/j.ydbio.2012.04.013

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

Review 1.  New model systems to illuminate thyroid organogenesis. Part I: an update on the zebrafish toolbox.

Authors:  Robert Opitz; Francesco Antonica; Sabine Costagliola
Journal:  Eur Thyroid J       Date:  2013-12-03

2.  A novel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression.

Authors:  Aurore Carré; Rasha T Hamza; Dulanjalee Kariyawasam; Loïc Guillot; Raphaël Teissier; Elodie Tron; Mireille Castanet; Corinne Dupuy; Mohamed El Kholy; Michel Polak
Journal:  Thyroid       Date:  2014-01-23       Impact factor: 6.568

3.  p53 dependent apoptotic cell death induces embryonic malformation in Carassius auratus under chronic hypoxia.

Authors:  Paramita Banerjee Sawant; Aritra Bera; Subrata Dasgupta; Bhawesh T Sawant; Narinder K Chadha; Asim K Pal
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

4.  Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo.

Authors:  Bo-Kai Wu; Rey-Yue Yuan; Huang-Wei Lien; Chin-Chun Hung; Pung-Pung Hwang; Rita Pei-Yeh Chen; Chun-Che Chang; Yung-Feng Liao; Chang-Jen Huang
Journal:  J Biomed Sci       Date:  2016-02-06       Impact factor: 8.410

5.  Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.

Authors:  Helena Motaln; Ana Koren; Kristina Gruden; Živa Ramšak; Christian Schichor; Tamara T Lah
Journal:  Oncotarget       Date:  2015-12-01

6.  Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo.

Authors:  Immacolata Porreca; Fulvio D'Angelo; Lucia De Franceschi; Alessandro Mattè; Michele Ceccarelli; Achille Iolascon; Alberto Zamò; Filomena Russo; Maria Ravo; Roberta Tarallo; Marzia Scarfò; Alessandro Weisz; Mario De Felice; Massimo Mallardo; Concetta Ambrosino
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

7.  A branching morphogenesis program governs embryonic growth of the thyroid gland.

Authors:  Shawn Liang; Ellen Johansson; Guillermo Barila; Daniel L Altschuler; Henrik Fagman; Mikael Nilsson
Journal:  Development       Date:  2018-01-25       Impact factor: 6.868

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.